Nomura SPARX Investment

Profile and portfolio

Parent Nomura HoldingsFounded 2021

Nomura SPARX Investment is the corporate venture arm of Nomura Holdings, a financial services company. It was founded in 2021. Sectors it names: biotech and life sciences.

Every figure links to its source

Where it invests

Geography

Investment regionsS1

Asia

Key facts

Fact	Value	Status	Source
Parent company	Nomura Holdings (TSE: 8604)	Single source	S1
Parent industry	Banking and financial services	Single source	S1
Founded	2021	Single source	S1
Status	Active	Single source	S1
Capital source	Parent and outside investors	Single source	S1

About Nomura Holdings

Item	Detail	Source
Listed as	TSE: 8604	S1
Headquarters	Japan	S1

Recent rounds

Date	Company	Round	Amount	Led by the firm	Source
2026-05-13	Anaut	Not stated	Not stated	No	S5
2025-04-09	LinqMed	Not stated	Not stated	No	S4
2024-02-29	Orizuru Therapeutics	Not stated	Not stated	No	S3
2022-11-30	SONIRE Therapeutics	Not stated	Not stated	No	S2

Portfolio

The firm's portfolio page lists 4 companies.S1

Shared portfolio with other corporate VCs

2 companies on the Nomura SPARX Investment portfolio page also appear on the portfolio page of at least one other firm in this directory. Matched by company website, or by name where no website is published.

Firm	Shared	Companies in common
LOTTE Holdings Healthcare and Biopharma CVC	1	LinqMed
Daiwa Corporate Investment	1	SONIRE Therapeutics

Companies backed by the most corporate VCs

Every company on the Nomura SPARX Investment list

4 companies, as listed on the firm's own website.S1 Read the firm's list.

Anaut
LinqMed
Orizuru Therapeutics
SONIRE Therapeutics

Sources

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by Nomura SPARX Investment or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.

Report a correction